ACAvneesh Chopra

Avneesh Chopra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Avneesh Chopra has a total of 68 co-authors. Here are the top co-authors by number of shared publications:

  • Sukumaran Anil

    Dental Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (deemed to be University), Pimpri, Pune, India

    4 shared publications
  • Nebu George Thomas

    Pushpagiri College of Dental Sciences, Perumthuruthy, Thiruvalla, India

    3 shared publications
  • Nebu George Thomas

    Pushpagiri Institute of Medical Sciences and Research Centre, Pushpagiri Medical Society, Tiruvalla 689101, Kerala, India; Pushpagiri College of Dental Sciences, Medicity, Tiruvalla, Kerala, India; Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil

    3 shared publications
  • Sajith Vellappally

    Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

    3 shared publications
  • Abdul Aziz Abdullah Al Kheraif

    Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia

    2 shared publications
  • Arne Sönke Schäfer

    Affiliation Department of Periodontology, Oral Medicine and Oral Surgery, Institute for Dental and Craniofacial Sciences, Charité-University Medicine Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

    2 shared publications

Latest Publications

  • Open Access

    Antibacterial and immunomodulatory core–shell nanofibrous membranes accelerate skin wound repair and regeneration

    by Avneesh Chopra, Rani Shine Raju, Raneesh Balakrishnan, Anju Rajan, Neethu Ninan, Richard Bright, Krasimir Vasilev, A.N. Ampadi, Nora Renz, Andrej Trampuz, et al.

  • Open Access

    Synergistic effects of fish scale–derived nanohydroxyapatite and arginine on enamel surface recovery: a multi-modal in vitro analysis

    by Nebu George Thomas, Vimal Thomas Oommen, Arun Mamachan Xavier, Revu Das, P. K. Binsi, Sajith Vellappally, Sachin Naik, Najm M. Alfrisany, Blessy M. Mani, Steffy M. Sunny, et al.

    Dental caries arises from an imbalance between demineralization and remineralization of dental hard tissues, leading to progressive mineral loss and early lesion formation. Fluoride enhances remineralization but mainly affects the enamel surface. Nanohydroxyapatite (n-HA), structurally similar to enamel apatite, may promote mineral deposition, while arginine increases local pH and supports remineralization. This in vitro study evaluated the combined remineralization potential of sustainably sourced, fish scale–derived n-HA and arginine, used alongside fluoride toothpaste, for early enamel lesions using a multimodal analytical approach. Forty human premolars were demineralized for 96 h to produce artificial lesions and randomly allocated into five groups ( n = 8): (1) fluoride toothpaste, (2) 10% n-HA, (3) 10% n-HA + 10% arginine, (4) fluoride toothpaste + 10% n-HA + 10% arginine, and (5) demineralized control. Specimens underwent pH cycling with respective remineralizing slurries for 28 days. Surface changes were evaluated using surface microhardness, scanning electron microscopy (SEM), atomic force microscopy (AFM), and Raman microscopy. The fluoride + n-HA + arginine group showed the greatest increase in microhardness (Vickers Hardness Number [VHN] 367.48 ± 26.95 kgf/mm²), significantly higher than the demineralized control (191.24 ± 13.86; p < 0.001). The n-HA + arginine group also showed a substantial increase in microhardness (319.10 ± 28.75 kgf/mm²). SEM and AFM analyses revealed greater surface smoothing and pore reduction in the combination group compared with fluoride alone, suggesting enhanced surface recovery and mineral deposition. Fish scale–derived n-HA combined with arginine enhances the in vitro remineralization potential of fluoride toothpaste and may represent a promising strategy for managing early enamel lesions. Graphical abstract The combination of fish scale-derived n-HA with arginine increases the enamel surface remineralization capacity of fluoride toothpaste in an in vitro caries model. Forty extracted human premolar teeth were submitted to artificial demineralization and divided into five groups ( n = 8): fluoride toothpaste, 10% n-HA, 10% n-HA + 10% arginine, fluoride toothpaste + 10% n-HA + 10% arginine, and demineralized control. After 28 days of pH cycling, the highest enamel microhardness was achieved by the group treated with fluoride toothpaste + 10% n-HA + 10% arginine (367.48 ± 26.95 VHN) compared with the demineralized control (191.24 ± 13.86 VHN; p < 0.001). The results indicated reduced surface porosity and structural imperfections of the enamel surface along with a homogeneous enamel surface, confirmed by morphological and topographical analysis by SEM and AFM. Abbreviations: n-HA, nanohydroxyapatite; VHN, Vickers hardness number; SEM, scanning electron microscopy; AFM, atomic force microscopy

  • Open Access

    AI Chatbots vs. Traditional Sources: Dental Health Literacy and Confidence Among Dental Patients-A Cross-Sectional Study

    by Sachin Naik, Sajith Vellappally, Mohammed Alateek, Yasser Fahad Alrayyes, Abdul Aziz Abdullah Al Kheraif, Talal Mughaileth Alnassar, Gerhard Schmalz, Ziyad Mohammed Alsultan, Haya Alayadi, Nandita Suresh, et al.


  • Open Access

    Oral health disparities among children with special healthcare needs: a comparative cross-sectional study

    by R. A. Rajeevan, K. Aparna, M. G. Elenjickal, T. G. Valliaveettil, E. Joseph, J. John, R. G. Varghese, R. Kunnaiah, S. Naik, S. Vellappally, et al.

    Purpose: Children with special healthcare needs (SHCN) often experience poorer oral health due to limitations in self-care, behavioral challenges, medical conditions, and reduced access to specialized dental services. This study aimed to assess and compare oral health behaviors, risk factors, and caries experience between children with SHCN and healthy controls, and to identify predictors of poor oral health outcomes. Method: In this cross-sectional study, 300 children (150 SHCN, 150 controls) underwent clinical examinations. Caries experience was assessed using the decayed, missing, and filled teeth (dmft/DMFT) indices, while oral hygiene status was evaluated with the Plaque Index and Gingival Index. Occlusal characteristics, dental trauma, and oral habits were also recorded. Behavioral assessment was performed using the Frankl Behavior Rating Scale (FBRS). Results: Children with SHCN demonstrated higher resistance to toothbrushing (42.7% vs. 6.7%, p = 0.001), more frequent swallowing of toothpaste (32.0% vs. 0%, p = 0.001), and a greater prevalence of habits such as mouth breathing (30.7% vs. 8.7%, p = 0.001). Interestingly, the control group showed significantly higher mean dmft scores (5.07 ± 3.56) compared to SHCN children (2.64 ± 4.22, p = 0.001). Regression analysis identified group (B = 2.44, p < 0.001) and age (B = − 0.125, p = 0.002) as significant predictors, explaining 12.2% of the variance. SHCN children exhibited distinct behavioral risk factors, while younger age was associated with higher caries experience. Conclusion: Children with SHCN exhibited significantly poorer oral health behaviors, including resistance to brushing, swallowing toothpaste, and abnormal oral habits, compared to controls. Interestingly, despite these behavioral disadvantages, caries experience was higher in the control group, underscoring the multifactorial and complex nature of caries development. Group type and age emerged as significant predictors of dmft.


  • Open Access

    In vitro and in vivo biocompatibility of a porcine cholecystic extracellular matrix (CECM) membrane for tissue regeneration

    by Betcy Thomas, Thomas George Velliavettil, Kanakarajan V. Pratheesh, Mekha Grace Varghese, Rani Shine Raju, Yogesh Bharat Dalvi, Sukumaran Anil, Nibu Varghese, Avneesh Chopra, Nebu George Thomas

    Background: Periodontal disease affects 3.5 billion people globally, resulting in annual treatment costs exceeding $54 billion. Guided tissue regeneration (GTR) membranes are essential for periodontal therapy, but commercially available options often suffer from limitations, including high cost, limited accessibility in resource-limited settings, and suboptimal mechanical properties. This study aimed to develop and characterize a novel porcine cholecystic extracellular matrix (CECM)-based GTR membrane and comprehensively evaluate its physicochemical properties, cytocompatibility, and in vivo biocompatibility compared to the commercially available Healiguide® membrane. Methods: CECM membranes were fabricated through systematic decellularization, lyophilization, and ethylene oxide (ETO) sterilization of porcine gallbladders. Surface characterization was performed using scanning electron microscopy (SEM) with quantitative pore analysis, and biochemical composition was assessed via Fourier Transform Infrared Spectroscopy (FTIR). MTT assays were performed on L929 fibroblast cells to evaluate cytocompatibility. Wound healing capacity was assessed using scratch assays monitored over 72 h. In vivo biocompatibility was evaluated through subcutaneous implantation in Sprague-Dawley rats, with histological analysis performed at 1, 2, 3, and 4 weeks post-implantation. Results: SEM analysis revealed that CECM membranes exhibited a heterogeneous, multilayered structure with larger average pore sizes compared to Healiguide® (18.2 ± 4.6 µm vs. 12.5 ± 3.2 µm, p < 0.05), facilitating enhanced cellular infiltration. FTIR confirmed the preserved integrity of collagen in both membranes, with CECM showing an enhanced glycoprotein content indicative of retained bioactive components. Cytocompatibility assessment demonstrated excellent cell viability for CECM, showing 97.4 ± 1.6%, 94.2 ± 1.8%, and 90.8 ± 1.4% viability at 20, 50, and 100 µg/mL CECM extracts, respectively. The scratch assay demonstrated superior wound healing capacity for CECM, with significantly enhanced wound closure at 72 h compared to Healiguide® (89.7 ± 6.1% vs. 79.4 ± 5.8%, p < 0.05). Subcutaneous implantation studies confirmed excellent in vivo biocompatibility, with CECM showing lower initial inflammatory response (inflammation score: 2.3 ± 0.5 vs 2.8 ± 0.6 at week 1, p < 0.05), enhanced vascularization (12.3 ± 2.1 vs 9.7 ± 1.8 vessels/hpf at week 3, p < 0.05), and superior tissue integration compared to commercial controls. Conclusion: The porcine CECM membrane demonstrated favorable physicochemical properties, excellent cytocompatibility, enhanced wound healing potential, and superior tissue integration characteristics compared to commercial GTR membranes. These preliminary findings provide a strong scientific foundation supporting the development of the GTR membrane for periodontal regenerative therapy.


  • Open Access

    Patients’ Acceptance and Intentions on Using Artificial Intelligence in Dental Diagnosis: Insights From Unified Theory of Acceptance and Use of Technology 2 Model

    by Sachin Naik, Sajith Vellappally, Mohammed Alateek, Yasser Fahad Alrayyes, Abdul Aziz Abdullah Al Kheraif, Talal Mughaileth Alnassar, Ziyad Mohammed Alsultan, Nebu George Thomas, Avneesh Chopra


  • Open Access

    Bioglass in dentistry: A comprehensive review of current applications and innovative frontiers

    by Nebu George Thomas, Fernando Gomes de Souza Junior, Neethu Ninan, Sukumaran Anil, Rani Shine Raju, Nibu Varghese, Avneesh Chopra, Sabu Thomas


  • Open Access

    Genetic analysis of cis-enhancers associated with bone mineral density and periodontitis in the gene SOST

    by Avneesh Chopra, Jiahui Song, January Weiner 3Rd, Dieter Beule, Arne S. Schaefer

    A haplotype block at the sclerostin (SOST) gene correlates with bone mineral density (BMD) and increased periodontitis risk in smokers. Investigating the putative causal variants within this block, our study aimed to elucidate the impact of linked enhancer elements on gene expression and to evaluate their role in transcription factor (TF) binding. Using CRISPR/dCas9 activation (CRISPRa) screening in SaOS-2 cells, we quantified disease-related enhancer activities regulating SOST expression. Additionally, in SaOS-2 cells, we investigated the influence of the candidate TFs CCAAT/enhancer-binding protein beta (CEBPB) on gene expression by antisense (GapmeR) knockdown, followed by RNA sequencing. The periodontitis-linked SNP rs9783823 displayed a significant cis-activating effect (25-fold change in SOST expression), with the C-allele containing a CEBPB binding motif (position weight matrix (PWM) = 0.98, Pcorrected = 7.7 x 10-7). CEBPB knockdown induced genome-wide upregulation but decreased epithelial-mesenchymal transition genes (P = 0.71, AUC = 2.2 x 10-11). This study identifies a robust SOST cis-activating element linked to BMD and periodontitis, carrying CEBPB binding sites, and highlights CEBPB’s impact on epithelial-mesenchymal transition.

  • Open Access

    Role of CRISPR‐Cas systems in periodontal disease pathogenesis and potential for periodontal therapy: A review

    by Aditi Chopra, Geeta Bhuvanagiri, Kshitija Natu, Avneesh Chopra

    Clustered regularly interspaced short palindromic repeats (CRISPRs) are DNA sequences capable of editing a host genome sequence. CRISPR and its specific CRISPR‐associated (Cas) protein complexes have been adapted for various applications. These include activating or inhibiting specific genetic sequences or acting as molecular scissors to cut and modify the host DNA precisely. CRISPR‐Cas systems are also naturally present in many oral bacteria, where they aid in nutrition, biofilm formation, inter‐ and intraspecies communication (quorum sensing), horizontal gene transfer, virulence, inflammation modulation, coinfection, and immune response evasion. It even functions as an adaptive immune system, defending microbes against invading viruses and foreign genetic elements from other bacteria by targeting and degrading their DNA. Recently, CRISPR‐Cas systems have been tested as molecular editing tools to manipulate specific genes linked with periodontal disease (such as periodontitis) and as novel methods of delivering antimicrobial agents to overcome antimicrobial resistance. With the rapidly increasing role of CRISPR in treating inflammatory diseases, its application in periodontal disease is also becoming popular. Therefore, this review aims to discuss the different types of CRISPR‐Cas in oral microbes and their role in periodontal disease pathogenesis and precision periodontal therapy.


  • Open Access

    Periodontitis Risk Variants at SIGLEC5 Impair ERG and MAFB Binding

    by R. Mueller, A. Chopra, H. Dommisch, A.S. Schaefer

    Periodontitis is a common complex inflammatory disease of the oral cavity. It is characterized by inflammation of gingival tissues and alveolar bone loss. Recently, a genome-wide association study and 2 genome-wide association study meta-analyses found 2 associated regions (haplotype blocks) at the inhibitory immune receptor gene SIGLEC5 to increase the risk for periodontitis. The aims of the current study were the identification of the putative causal variants underlying these associations, characterization of their molecular biological effects, and validation of SIGLEC5 as the target gene. We mapped the associated single-nucleotide polymorphisms to DNA elements with predictive features of regulatory functions and screened the associated alleles for transcription factor (TF) binding sites. Antibody electrophoretic mobility shift assays (EMSAs) with allele-specific probes were used to identify TF binding and to quantify allele-specific effects on binding affinities. Luciferase reporter assays were used to quantify the effect directions and allele-specific strength of the associated regulatory elements. We used CRISPR-dCas9 gene activation to validate SIGLEC5 as a target of the association. EMSA in peripheral blood mononuclear cells showed that E-26 transformation–specific TF-related gene (ERG) binds at rs11084095, with almost complete loss of binding at the minor A-allele. Allele-specific reporter genes showed enhancer function of the DNA sequence at rs11084095, which was abrogated in the background of the A-allele. EMSA in B lymphocytes showed that TF MAF bZIP (MAFB) binds at the common G-allele of rs4284742, whereas the minor A-allele reduced TF binding by 69%, corresponding to 9-fold reduction of luciferase reporter gene activity by the A-allele. Using CRISPR-dCas9, we showed that the enhancer at rs4284742 strongly activated SIGLEC5 expression, validating this gene as the target gene of the association. We conclude that rs11084095 and rs4284742 are putatively causal for the genome-wide significant associations with periodontitis at SIGLEC5 that impair ERG and MAFB binding, respectively.